Aeon Acquisition Corp

Aeon Acquisition Corp (Nasdaq: AEON) is a blank-check company that completed its initial public offering in 2021, sponsored by Aeon Sponsor LLC. The company filed its S-1/A registration statement amendment with the SEC on March 11, 2021, targeting the healthcare and consumer wellness sector. Aeon subsequently announced a business combination with Gelesis, an Italian-founded biotech focused on gastrointestinal-based weight management therapies, and the merger was completed in January 2022, with the combined company trading under the ticker GLS. The SPAC is now closed following the consummation of that de-SPAC transaction. For full filing history, deal terms, and sponsor background on Aeon Acquisition Corp, sign up for complete data access at SpacDesk.